Prosus leads €480M round in Alan at €5.5B valuation to fuel AI-powered healthcare
What's the deal? Alan, the French AI-native health insurance startup, has raised €480 million in a new round that values it at €5.5 billion (about $6.3 billion). Global technology group ProsusDealroom has a profile for this one. Try Dealroom → led with a €400 million (US$460 million) investment spanning both primary and secondary equity, joined by existing backers Index Ventures and Ontario Teachers' Pension PlanDealroom has a profile for this one. Try Dealroom → (via its Teachers' Venture Growth arm), plus new investor Dara Holdings.
The capital will fast-track Alan's international expansion and the development of its AI-powered healthcare products, with Prosus offering access to its consumer ecosystem and its Large Commerce Model.
Why now? Alan reached more than €800 million in annual recurring revenue as of Q1 2026, up 53% year on year, and is profitable in France, its largest market. It serves over 1.1 million members across France, Spain, Belgium and Canada while scaling with limited headcount growth — the operating leverage of an AI-led model that makes it a natural target for a corporate investor hunting AI applications embedded in established industries.
What could go wrong? Insurance is a slow, heavily regulated industry, and embedding AI into core workflows is harder than it looks. The financing is also subject to regulatory approvals, including from the relevant French financial authorities, before it closes.
The signal: Alan bills itself as a prevention-insurance platform bringing insurance, care and prevention into a single experience. Reaching late-stage maturity at €5.5B makes it one of Europe's most valuable insurtech names — and a corporate-backed bet that the value in AI healthcare sits at the application layer, not in the underlying models.
